Isabelle Chereau
Overview
Explore the profile of Isabelle Chereau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
650
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gerentes M, Lajnef M, Szoke A, Aouizerate B, Berna F, Clery M, et al.
Drug Saf
. 2025 Mar;
PMID: 40088341
Background: The life expectancy of patients with schizophrenia is reduced, partly due to cardiovascular diseases. Antipsychotics are associated with QT interval prolongation, which is a risk factor for arrhythmia and...
2.
Barbosa S, Tamouza R, Leboyer M, Aouizerate B, Andrieu C, Andre M, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2025 Mar;
137:111304.
PMID: 40023308
Background: Schizophrenia (SZ) commonly manifests through multiple relapses, each impeding the path to recovery and incurring personal and societal costs. Despite the identification of various risk factors associated to the...
3.
Donde C, Coulon N, Turbe H, Andre M, Boyer L, Capdevielle D, et al.
Schizophr Res
. 2023 Dec;
264:105-112.
PMID: 38128341
Background: Childhood Attention-deficit/hyperactivity disorder (C-ADHD) is a neurodevelopmental disorder, associated with an increased risk of subsequent schizophrenia. The objective of the present study was to determine the prevalence of C-ADHD...
4.
Misdrahi D, Dupuy M, Dansou Y, Boyer L, Berna F, Capdevielle D, et al.
Transl Psychiatry
. 2023 Nov;
13(1):341.
PMID: 37935695
Schizophrenia is characterized by the most salient medication adherence problems among severe mental disorders, but limited prospective data are available to predict and improve adherence in this population. This investigation...
5.
Szoke A, Richard J, Fond G, Misdrahi D, Lajnef M, Aouizerate B, et al.
J Psychiatr Res
. 2023 Mar;
161:206-212.
PMID: 36934602
Caffeine is the most consumed psychoactive substance worldwide. Previous studies suggested higher caffeine consumption in subjects with schizophrenia spectrum disorders (SSD) as well as associations with symptoms, medication and medication...
6.
Roux P, Faivre N, Urbach M, Aouizerate B, Brunel L, Capdevielle D, et al.
Schizophr Res
. 2023 Jan;
252:48-55.
PMID: 36623435
Background: Social metacognition is still poorly understood in schizophrenia, particularly its neuropsychological basis and its impact on insight and medication adherence. We therefore quantified social metacognition as the agreement between...
7.
Donde C, Dubertret C, Fond G, Andre M, Berna F, Boyer L, et al.
Eur Arch Psychiatry Clin Neurosci
. 2022 Dec;
273(8):1773-1783.
PMID: 36583738
Schizophrenia is associated with early neurodevelopmental disorders, including most frequently learning disorders (LD), among them dyslexia and dyspraxia. Despite the demonstrated links between schizophrenia and LD, specific clinical patterns of...
8.
Mallet J, Godin O, Dansou Y, Mazer N, Scognamiglio C, Berna F, et al.
Psychol Med
. 2022 Sep;
53(11):5279-5290.
PMID: 36073848
Background: Tobacco use is common in subjects with schizophrenia (SZ) and has sometimes been associated with better functioning in short-term studies. Only few studies embrace an extensive examination of tobacco...
9.
Raffard S, Bayard S, Eisenblaetter M, Attal J, Andrieu C, Chereau I, et al.
Vaccines (Basel)
. 2022 Aug;
10(8).
PMID: 36016116
Schizophrenia patients are at high risk of developing severe COVID-19 outcomes but recent evidence suggests that they are under-vaccinated. This study explored the role of potential attitudinal barriers by comparing...
10.
Foiselle M, Barbosa S, Godin O, Wu C, Boukouaci W, Andre M, et al.
Brain Behav Immun Health
. 2022 Apr;
22:100436.
PMID: 35469211
Background: Metabolic syndrome (MetS) is a highly prevalent and harmful medical disorder often comorbid with psychosis where it can contribute to cardiovascular complications. As immune dysfunction is a key shared...